NCT00482079已完成2 期
A Multicenter, Double-Blind, Randomized, Placebo- and Active-Controlled Dose-Range Finding Study of MK0431 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 743
- 主要终点
- To asses the effectiveness of MK0431 compared to placebo
研究概览
简要总结
A dose-ranging study of MK0431 in patients with type 2 diabetes who have inadequate control of their blood sugar.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 21 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 21 to 70, You are a man or non-pregnant woman
排除标准
- •Have a history of type I diabetes
- •You are on a weight loss program with ongoing weight loss or taking weight loss medications
- •You have a history of minor surgery
- •You have received investigational drugs within 8 weeks of study start
- •You have hepatitis B or C
结局指标
主要结局
To asses the effectiveness of MK0431 compared to placebo
时间窗: over 12 weeks
次要结局
- To test the safety and tolerability of MK0431 in patients with type 2 diabetes
研究者
相似试验
已完成
2 期
A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)Type II Diabetes MellitusNCT00481663Merck Sharp & Dohme LLC555
已完成
2 期
MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)Type 2 Diabetes MellitusNCT00371007Merck Sharp & Dohme LLC126
已完成
2 期
A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2NCT03235050AstraZeneca834
已完成
3 期
Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes MellitusType 2 DiabetesNCT01451398Mannkind Corporation353
已完成
3 期
A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)Type 2 Diabetes Mellitus, Non Insulin DependentDiabetes Mellitus, Non-Insulin-DependentNCT00701090Merck Sharp & Dohme LLC1,035